Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum

DS Knopman, CR Jack Jr, ES Lundt, SD Weigand… - Neurobiology of …, 2016 - Elsevier
The availability of antemortem biomarkers for Alzheimer's disease (AD) enables monitoring
the evolution of neurodegenerative processes in real time. Pittsburgh compound B (PIB) …
被引用次数：32 相关文章

Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.

DS Knopman, CR Jack Jr, ES Lundt… - Neurobiology of …, 2016 - europepmc.org
The availability of antemortem biomarkers for Alzheimer's Disease (AD) enables monitoring
the evolution of neurodegenerative processes in real time. Pittsburgh compound B (PIB) …

Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum

DS Knopman, CR Jack, ES Lundt, SD Weigand… - Neurobiology of …, 2016 - infona.pl
The availability of antemortem biomarkers for Alzheimer's disease (AD) enables monitoring
the evolution of neurodegenerative processes in real time. Pittsburgh compound B (PIB) …

Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum

DS Knopman, CR Jack, ES Lundt… - Neurobiology of …, 2016 - pure.johnshopkins.edu
The availability of antemortem biomarkers for Alzheimer's disease (AD) enables monitoring
the evolution of neurodegenerative processes in real time. Pittsburgh compound B (PIB) …

Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum

DS Knopman, CR Jack Jr, ES Lundt… - Neurobiology of …, 2016 - pubmed.ncbi.nlm.nih.gov
The availability of antemortem biomarkers for Alzheimer's disease (AD) enables monitoring
the evolution of neurodegenerative processes in real time. Pittsburgh compound B (PIB) …
[HTML] nih.gov

[HTML][HTML] Evolution of Neurodegeneration Imaging Biomarkers from Clinically Normal to Dementia in the Alzheimer Disease Spectrum

DS Knopman, CR Jack Jr, ES Lundt… - Neurobiology of …, 2016 - ncbi.nlm.nih.gov
The availability of antemortem biomarkers for Alzheimer's Disease (AD) enables monitoring
the evolution of neurodegenerative processes in real time. Pittsburgh compound B (PIB) …

Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum

DS Knopman, CR Jack, ES Lundt… - Neurobiology …, 2016 - mayoclinic.elsevierpure.com
The availability of antemortem biomarkers for Alzheimer's disease (AD) enables monitoring
the evolution of neurodegenerative processes in real time. Pittsburgh compound B (PIB) …

Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.

DS Knopman, CR Jack Jr, ES Lundt… - Neurobiology of …, 2016 - europepmc.org
The availability of antemortem biomarkers for Alzheimer's Disease (AD) enables monitoring
the evolution of neurodegenerative processes in real time. Pittsburgh compound B (PIB) …